SIRT6 is downregulated in human liver cancer, and SIRT6 knockout in HCC induces oncogenic changes including global hypomethylation, decreased apoptosis, and metabolic changes, such as increased fat deposition and hypoglycemia [38]. Here, SIRT6 is linked to liver cancer.